Markets

Market

News Details

(11/02/2026 16:16)

Biogen Pharmachem - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 11Th February 2026.

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Wednesday 11th February 2026 at the Registered Office of the Company and transacted the following major businesses: \r\n1.) Considered and approved Un-audited financial results for the quarter and nine months ended as on 31st December, 2025.\r\nThe board meeting commenced at 03:30 PM and concluded at 04:00 PM\r\n\r\nPlease take the above intimation in your records.\r\n\r\nThanking You.\r\n

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.